Michael Maline is a partner in Goodwin Procter's Technology Companies & Life Sciences Group. He practices corporate and securities law with a particular emphasis on representing clients in public and private capital markets transactions such as IPOs, follow-on offerings and private placements of equity and debt securities. His clients include global investment banks, issuers, venture capital and later stage investors and his experience extends to a variety of industries ranging from life sciences, technology and other growth sectors to media and retail/consumer goods.

Mr. Maline is widely regarded as a leader in the area of alternative financing techniques, such as Confidentially Marketed Public Offerings (“CMPOs”), Registered Direct Offerings (“RDs”), Private Investments in Public Equity (“PIPEs”) and At-the-Market Offerings (“ATMs”). Under his leadership, Goodwin consistently ranks as one of the most active law firms in the United States advising on these transactions. Since 2008, Mr. Maline has completed more than 185 offerings of securities totaling in excess of $6 billion in gross proceeds.